Positron emission tomography study of [ 11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain

THA (1,2,3,4-tetrahydro-9-amino-acridine, tacrine), a potential therapeutic agent for patients suffering from Alzheimer's disease, has multiple pharmacological sites of action in the brain. In order to study the cerebral binding sites of THA in vivo, we labeled a close derivative of THA with ca...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmacology Vol. 236; no. 2; pp. 229 - 238
Main Authors Tavitian, Bertrand, Pappata, Sabina, Bonnot-Lours, Sophie, Prenant, Christian, Jobert, Antoinette, Crouzel, Christian, Di Giamberardino, Luigi
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 19.05.1993
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:THA (1,2,3,4-tetrahydro-9-amino-acridine, tacrine), a potential therapeutic agent for patients suffering from Alzheimer's disease, has multiple pharmacological sites of action in the brain. In order to study the cerebral binding sites of THA in vivo, we labeled a close derivative of THA with carbon 11 for positron emission tomography (PET) analysis. We report the biodistribution of this compound, 1,2,3,4-tetrahydro-9-[ 11C]methylaminoacridine ([ 11C]MTHA), in the rodent and describe the first PET experiments in non-human primates. The distribution of [ 11C]MTHA in baboon brain, although rather diffuse in the gray matter, showed a higher concentration in the cortex and basal ganglia than in the cerebellum and binding could be displaced (50%) by cold THA. These results suggest that [ 11C]MTHA is a promising PET ligand for the study of the cerebral binding of THA.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-2999
1879-0712
DOI:10.1016/0014-2999(93)90593-7